Entering text into the input field will update the search result below

Pfizer/BioNTech, Moderna updated boosters cleared in U.S. for children as young as six months

Dec. 08, 2022 10:09 AM ETPfizer Inc. (PFE), BNTX, MRNABy: Dulan Lokuwithana, SA News Editor16 Comments

Headquarters of US Food and Drug Administration (FDA)


The Food and Drug Administration (FDA) announced Thursday that the Omicron-adjusted COVID vaccines developed by Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) are authorized in the U.S. for use as boosters in children as young

Recommended For You

Comments (16)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Evil I pray that everyone promoting this poison, sees the weight of the world unleashed on them for their complicity! NCSWIC
soral a raison profile picture
The reason why so many vaccinated people suddenly die of myocarditis, pericarditis, or other unexplained causes is because of the stress they must endure from the continued existence of the unvaccinated. Yes, thats right, the SCIENCE proved it in a peer-reviewed article posted on PubMed.
Bright spot profile picture
@soral a raison And people laughed and laughed at this.
So, “healthy” young children who have almost zero risk of a mild cold like virus, covid will get a booster for injections of untested gene cell therapy incorrectly called a vaccine for booster number N to infinity for the rest of their lives, while data coming in clearly shows serious adverse reactions. Its even more egregious considering that omicron and bivalence covid variants are already extinct. Unfortunately there is not a vaccine for stupidity.
@mac ron Big pharma and their allies at CDC keep pushing FEAR
Haribo profile picture
How have we, all of us, allowed this insanity?
Bright spot profile picture
Bunch of those kids will die from clots and be blamed on SIDS.
@Bright spot what is this based on?
Bright spot profile picture
@dickweitz Cover ups
I don't know what to think of the longevity of Moderna's MRNA platform for the long haul, but the " STOCK " is in an interesting point. Been putting in triple bottom this year with a Divergent setup on weekly charts.

Stock is above 200 day MA ( bullish )
50 day MA is crossing the 200 day as we speak ( GOLDEN CROSS = bullish )
Currently at price level ( 183 ) testing Resistance levels looking for upside breakout or reversal from prior resistance.

Clearing and holding above the 200 day MA looks like a longer bull leg could be forming after the Breakout to upside. 190 / 200 level is current S-T / L-T resistance levels that need to be cleared to confirm sustained longer move up as I read the chart
lshiang profile picture
@JakerTrade Facing the reality, the Market seems to finally admit it has undervalued Pfizer and pushed its stock price up. I think Pfizer has >20% upward potential compared to its peers.
JDDurango profile picture
Good Lord...what parent in their right mind would do this.
svalbard10 profile picture
There is no way I'd get this shot for young children. Completely unnecessary.
Joe de Mencia profile picture
there are so many different shots now how can people even keep up ? and another new one is coming soon, another updated booster. this is crazy
Big DD profile picture
Give your 6-month-old the jab... brought to you by those you can trust at Murder, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.